SEC sues NY private equity adviser Lucas over alleged $8M investor cash grab

A New York private equity adviser is accused of siphoning at least $8 million from investor funds to bankroll rent, alimony, his wedding, and a New Hampshire newspaper he owned. 

That is the picture painted by the Securities and Exchange Commission in a civil case against Jay S. Lucas and his firm Lucas Brand Equity LLC, filed in the U.S. District Court for the Southern District of New York (Securities and Exchange Commission v. Lucas et al., No. 1:26-cv-03408). 

According to the filing, Lucas and his firm raised more than $50 million from hundreds of investors across three private equity funds pitched as a play on the wellness, beauty, and skincare sectors. The SEC alleges that between 2017 and 2025, a substantial chunk of that money never made it to portfolio companies. Instead, the agency claims, it was routed through XL7 Group LLC — an entity owned by Lucas and his wife that the SEC describes as a "slush fund masquerading as a business account." 

For wealth managers and fund compliance officers, the more interesting parts of the filing sit in the back office. 

The SEC says the funds' offering documents disclosed a 1.5% management fee — but Fund 2 was allegedly hit with an additional $4.1 million in purported expenses between 2018 and 2024 that never showed up clearly in quarterly reports. The agency alleges those amounts were buried in a balance-sheet line called "Due from Affiliates," which grew to roughly $9.27 million for Fund 2 by Q3 2024 — about 35% of the fund's reported assets. 

There are also questions about service providers that any allocator running due diligence would flag. The complaint says Fund 1's partnership agreement required audited financial statements, yet the SEC alleges no independent auditor was ever retained. Investor materials for Fund 2, the agency claims, also continued to tout SteelBridge as a third-party administrator long after the firm resigned in December 2018 over unpaid bills. 

Conflicts of interest sit at the heart of the case. The largest single recipient of fund money was Immunocologie, a struggling skincare company. According to the SEC, it was run by Lucas's wife and chaired by Lucas himself — facts the agency says were never disclosed in offering documents or quarterly reports. The filing also claims investors were told the funds held an equity stake in Immunocologie when, in reality, their interest had been converted into promissory notes. 

The SEC further alleges what it calls "Ponzi-like payments," including roughly $1.4 million moved from Fund 2 to an older Lucas vehicle, LGC, between 2018 and 2022 — with two 2018 transfers funneled through Immunocologie's account in a way the agency says was designed to make them look like portfolio investments. For Fund 3, launched in 2024, the agency says only about 16% of the roughly $4 million raised actually reached portfolio companies. 

The SEC has charged Lucas and the firm with violations of Section 10(b) of the Exchange Act and Rule 10b-5, Section 17(a) of the Securities Act, and Sections 206(1), 206(2), and 206(4) of the Advisers Act, plus Rule 206(4)-8. It is seeking permanent injunctions, disgorgement with prejudgment interest, civil penalties, and an industry bar that would keep Lucas from associating with any investment adviser or participating in securities offerings outside his own personal account. 

The allegations have not been tested in court, no ruling has been made, and the defendants have not yet filed a response.